Triple-negative breast cancers (TNBCs) comprise most of breast cancer phenotypes that are difficult to treat because they do not express estrogen receptor (ER), progesterone receptor (PR), and HER2 genes [1]. This evidence concerns the gene PGR and triple-negative breast carcinoma.